↓ Skip to main content

Natalizumab for relapsing remitting multiple sclerosis

Overview of attention for article published in Cochrane database of systematic reviews, October 2011
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
13 tweeters
facebook
1 Facebook page
wikipedia
3 Wikipedia pages

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
247 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Natalizumab for relapsing remitting multiple sclerosis
Published in
Cochrane database of systematic reviews, October 2011
DOI 10.1002/14651858.cd007621.pub2
Pubmed ID
Authors

Eugenio Pucci, Giorgio Giuliani, Alessandra Solari, Silvana Simi, Silvia Minozzi, Carlo Di Pietrantonj, Ian Galea

Abstract

Natalizumab (NTZ) (Tysabri(®)) is a monoclonal antibody that inhibits leukocyte migration across the blood-brain barrier, thus reducing inflammation in central nervous system, and has been approved worldwide for the treatment of relapsing-remitting multiple sclerosis (RRMS).

Twitter Demographics

The data shown below were collected from the profiles of 13 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 247 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 2 <1%
Brazil 2 <1%
Italy 1 <1%
United Kingdom 1 <1%
Sri Lanka 1 <1%
Chile 1 <1%
Unknown 239 97%

Demographic breakdown

Readers by professional status Count As %
Student > Master 41 17%
Student > Bachelor 31 13%
Researcher 29 12%
Student > Ph. D. Student 26 11%
Other 17 7%
Other 48 19%
Unknown 55 22%
Readers by discipline Count As %
Medicine and Dentistry 93 38%
Psychology 17 7%
Nursing and Health Professions 17 7%
Agricultural and Biological Sciences 10 4%
Social Sciences 9 4%
Other 31 13%
Unknown 70 28%

Attention Score in Context

This research output has an Altmetric Attention Score of 35. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 November 2020.
All research outputs
#684,961
of 16,983,585 outputs
Outputs from Cochrane database of systematic reviews
#1,759
of 11,604 outputs
Outputs of similar age
#3,446
of 108,882 outputs
Outputs of similar age from Cochrane database of systematic reviews
#9
of 69 outputs
Altmetric has tracked 16,983,585 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,604 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 24.5. This one has done well, scoring higher than 84% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,882 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 86% of its contemporaries.